These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726 [TBL] [Abstract][Full Text] [Related]
9. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer. Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448 [TBL] [Abstract][Full Text] [Related]
10. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding. Zhang Z; Zhang P; Hu H PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062 [TBL] [Abstract][Full Text] [Related]
11. Abnormal glycosylation of dystroglycan in human genetic disease. Hewitt JE Biochim Biophys Acta; 2009 Sep; 1792(9):853-61. PubMed ID: 19539754 [TBL] [Abstract][Full Text] [Related]
12. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342 [TBL] [Abstract][Full Text] [Related]
13. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576 [TBL] [Abstract][Full Text] [Related]
14. Endocytic trafficking of laminin is controlled by dystroglycan and is disrupted in cancers. Leonoudakis D; Huang G; Akhavan A; Fata JE; Singh M; Gray JW; Muschler JL J Cell Sci; 2014 Nov; 127(Pt 22):4894-903. PubMed ID: 25217627 [TBL] [Abstract][Full Text] [Related]
15. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. Patnaik SK; Stanley P J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414 [TBL] [Abstract][Full Text] [Related]
16. Investigating the functions of LARGE: lessons from mutant mice. Hewitt JE Methods Enzymol; 2010; 479():367-86. PubMed ID: 20816177 [TBL] [Abstract][Full Text] [Related]
17. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806 [TBL] [Abstract][Full Text] [Related]
18. Fer kinase regulates cell migration through α-dystroglycan glycosylation. Yoneyama T; Angata K; Bao X; Courtneidge S; Chanda SK; Fukuda M Mol Biol Cell; 2012 Mar; 23(5):771-80. PubMed ID: 22238358 [TBL] [Abstract][Full Text] [Related]
19. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570 [TBL] [Abstract][Full Text] [Related]
20. Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring. Weir ML; Oppizzi ML; Henry MD; Onishi A; Campbell KP; Bissell MJ; Muschler JL J Cell Sci; 2006 Oct; 119(Pt 19):4047-58. PubMed ID: 16968749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]